≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Chronic conjunctivitis

DOID EFO Endpoint Browser PheWeb

H7_CONJUNCTIVITISCHRON

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — H10.4
  • Hospital discharge: ICD-9 — 3721
  • Cause of death: ICD-10 — H10.4
  • Cause of death: ICD-9 — 3721

2 out of 7 registries used, show all original rules.

1129

4. Check minimum number of events

None

1129

5. Include endpoints

None

1129

6. Filter based on genotype QC (FinnGen only)

1129

Control definitions (FinnGen only)

Control exclude
H7_CONJUNCTIVA

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H10
Name in latin
Conjunctivitis chronica

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 8152 4892 3233
Only index persons 7374 4515 2859
Unadjusted period prevalence (%)
Whole population 0.12 0.14 0.09
Only index persons 0.14 0.17 0.11
Median age at first event (years)
Whole population 38.99 44.07 31.30
Only index persons 40.61 44.61 34.30

-FinnGen-

Key figures

All Female Male
Number of individuals 1129 790 339
Unadjusted period prevalence (%) 0.23 0.27 0.15
Median age at first event (years) 48.21 48.22 48.18

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1001
Matched controls
10010
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
S01GX01
ATC
cromoglicic acid; ophthalmic
20.6
323.0
624
745
H10.4
ICD-10 Finland
Chronic conjunctivitis
4503599627370496.0
323.0
984
*
S01GX05
ATC
lodoxamide; ophthalmic
112.0
205.2
219
25
H04.10
ICD-10 Finland
Dry eye syndrome
13.6
200.8
385
440
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
6.8
170.4
704
2577
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
5.0
117.7
535
1869
XQ800
NOMESCO Finland
Prick test
8.1
88.3
216
329
S01GX09
ATC
olopatadine; ophthalmic
26.3
83.4
117
50
H10.5
ICD-10 Finland
Blepharoconjunctivitis
28.6
78.9
108
42
S01GX02
ATC
levocabastine; ophthalmic
9.5
70.2
152
185
S01GX08
ATC
ketotifen; ophthalmic
12.2
56.8
106
96
H01.0
ICD-10 Finland
Blepharitis
7.1
56.2
146
234
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
7.7
54.3
133
195
S01GX04
ATC
nedocromil; ophthalmic
28.4
54.2
74
28
R06AE07
ATC
cetirizine; oral
2.8
52.5
554
3062
R06AX27
ATC
desloratadine; oral
3.1
52.5
393
1742
H10.1
ICD-10 Finland
Acute atopic conjunctivitis
16.1
50.4
83
56
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
4.8
48.1
174
416
H10.9
ICD-10 Finland
Conjunctivitis, unspecified
6.7
45.6
123
206
R06AX22
ATC
ebastine; oral
3.4
42.9
245
872
L20.0
ICD-10 Finland
Besnier prurigo
5.2
42.1
140
303
S01GX06
ATC
emedastine; ophthalmic
24.0
41.4
59
26
E0000UV
ATC
NA
2.5
41.1
481
2682
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
7.9
40.1
95
131
R01AD08
ATC
fluticasone; nasal
2.6
38.5
358
1741
J45.0
ICD-10 Finland
Predominantly allergic asthma
4.2
36.0
149
401
E000001
ATC
NA
2.8
35.6
270
1152
S01AA01
ATC
chloramphenicol; ophthalmic (antibiotics)
5.5
35.5
110
218
R06AX13
ATC
loratadine; oral
3.1
34.0
213
797
H02AB06
ATC
prednisolone; systemic
2.2
32.5
505
3121
XQ802
NOMESCO Finland
Epicutan test
6.6
31.9
85
139
S01XA18
ATC
ciclosporin; ophthalmic
31.2
31.9
42
14
H01.80
ICD-10 Finland
Prolonged inflammation in the edge of the eyelid
28.0
31.7
43
16
Z2221
NOMESCO Finland
Medical doctor
2.4
31.3
348
1819
R03DC03
ATC
montelukast; oral
2.9
30.4
216
874
R01AD09
ATC
mometasone; nasal
2.2
30.2
504
3177
R06AE09
ATC
levocetirizine; oral
3.0
30.1
197
755
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
5.5
30.0
93
184
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
5.2
29.8
97
203
S01BC03
ATC
diclofenac; ophthalmic
8.8
29.4
64
77
317
Kela drug reimbursment
Topical pimecrolimus and tacrolimus
16.4
29.2
47
30
H02AB07
ATC
prednisone; oral
2.9
28.9
194
754
Z3231
NOMESCO Finland
Registered nurse
2.3
28.5
339
1815
R03AC02
ATC
salbutamol; inhalant
2.1
28.0
575
3912
J30.3
ICD-10 Finland
Other allergic rhinitis
5.7
26.7
79
148
ZXD10
NOMESCO Finland
Scheduled procedure
2.1
26.0
434
2675
J31.0
ICD-10 Finland
Chronic rhinitis
3.6
25.8
126
388
S01KA02
ATC
hypromellose; ophthalmic
9.0
24.8
53
62
S01BA01
ATC
dexamethasone; ophthalmic (corticosteroids, plain)
5.8
24.3
70
127
D11AH01
ATC
tacrolimus; topical
20.1
23.6
35
18
S01AD03
ATC
aciclovir; ophthalmic
5.2
23.4
74
150
J01AA02
ATC
doxycycline; systemic
2.1
22.6
774
6195
J45.9
ICD-10 Finland
Asthma, unspecified
2.5
22.4
208
966
D07AA02
ATC
hydrocortisone; topical
2.6
21.3
179
785
C01CA24
ATC
epinephrine; parenteral
3.9
21.2
91
251
H10.0
ICD-10 Finland
Mucopurulent conjunctivitis
4.0
21.0
87
232
R03AC03
ATC
terbutaline; inhalant
2.6
20.7
171
743
H16.9
ICD-10 Finland
Keratitis, unspecified
8.9
20.3
43
50
D07AB02
ATC
hydrocortisone butyrate; topical
2.1
20.1
294
1677
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.9
19.8
131
499
R4110
NOMESCO Finland
Physiotherapy
2.1
19.7
290
1655
A02BC05
ATC
esomeprazole; systemic
1.9
19.6
412
2694
R06AX26
ATC
fexofenadine; oral
3.5
19.6
97
301
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
19.6
421
2774
R01AD01
ATC
beclometasone; nasal
2.5
19.5
175
793
Z3226
NOMESCO Finland
Physiotherapist
2.2
19.4
221
1126
F29
ICPC
Eye symptom/complaint other
3.2
19.3
108
366
XCK10
NOMESCO Finland
Photography of fundus of eye
2.9
19.3
123
456
N02AX02
ATC
tramadol; systemic, rectal
1.9
19.0
410
2695
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.3
19.0
189
903
E000002
ATC
NA
2.7
18.9
139
563
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.0
18.8
295
1718
XCH00
NOMESCO Finland
Eye pressure measurement
4.6
18.7
66
151
D07AB08
ATC
desonide; topical
2.7
18.7
138
561
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
2.2
18.6
216
1107
S01AX11
ATC
[U] ofloxacin; ophthalmic
5.0
18.6
60
125
J01FA06
ATC
roxithromycin; oral
1.9
18.5
415
2757
J01FA10
ATC
azithromycin; systemic
1.8
18.4
615
4664
R07.4
ICD-10 Finland
Chest pain, unspecified
2.1
18.2
263
1481
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
18.1
467
3246
H10
ICD-10 Finland
Conjunctivitis
3.3
18.1
94
303
CFA20
NOMESCO Finland
Biopsy of conjunctiva
53.5
18.0
21
*
H16.0
ICD-10 Finland
Corneal ulcer
4.3
17.9
67
163
J01DB01
ATC
cefalexin; oral
2.0
17.8
814
6848
3721A
ICD-9 Finland
Disorders of conjunctiva, Chronic conjunctivitis
+∞
17.8
17
*
R01AD12
ATC
fluticasone furoate; nasal
1.9
17.5
321
1976
ZXA00
NOMESCO Finland
Right side
2.0
17.5
277
1613
H16.2
ICD-10 Finland
Keratoconjunctivitis
14.2
17.3
29
21
R01AD05
ATC
budesonide; nasal
3.1
17.3
99
341
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
11.4
17.3
32
29
J05AB11
ATC
valaciclovir; oral
2.4
17.1
153
687
D11AX14
ATC
[U] tacrolimus; topical
26.1
16.9
23
9
R03BA02
ATC
budesonide; inhalant
2.2
16.8
200
1033
A06AC01
ATC
ispaghula (psylla seeds); oral
2.0
16.6
243
1368
D07AC13
ATC
mometasone; topical
1.9
16.6
291
1758
ZXA05
NOMESCO Finland
Left side
2.0
16.5
252
1445
R06.0
ICD-10 Finland
Dyspnoea
2.0
16.2
243
1381
Z01.8
ICD-10 Finland
Other specified special examinations
2.0
16.2
227
1255
ZXD20
NOMESCO Finland
Day surgery
2.3
15.9
154
722
H19.3*M35.0
ICD-10 Finland
Keratoconjunctivitis sicca
34.0
15.8
20
6
H11.1
ICD-10 Finland
Conjunctival degenerations and deposits
86.4
15.6
17
*
XCK00
NOMESCO Finland
Perimetry
3.2
15.6
87
293
D07AD01
ATC
clobetasol; topical
2.2
15.5
167
822
M03BX02
ATC
tizanidine; oral
1.7
15.4
603
4680
ZXE00
NOMESCO Finland
One hour or less
1.8
15.3
404
2782
J01AA07
ATC
tetracycline; systemic
2.2
15.3
169
840
D07AC01
ATC
betamethasone; topical
1.8
15.2
329
2124
ZXE10
NOMESCO Finland
More than one and less than three hours
1.8
15.2
367
2455
L30.9
ICD-10 Finland
Dermatitis, unspecified
2.1
15.1
189
995
S01BA04
ATC
prednisolone; ophthalmic (corticosteroids, plain)
6.4
15.0
39
63
M25.5
ICD-10 Finland
Pain in joint
1.9
14.9
290
1804
N03AX16
ATC
pregabalin; oral
1.9
14.8
241
1405
TCC40
NOMESCO Finland
Closure of lacrimal canaliculus with plug
57.5
14.8
17
*
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
5.9
14.8
41
72
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
2.9
14.6
92
337
UJF32
NOMESCO Finland
Coloscopy
1.9
14.6
252
1500
J01DA01
ATC
[U] cefalexin; systemic
1.7
14.3
606
4758
J45
ICD-10 Finland
Asthma
2.6
14.2
111
462
R03AK07
ATC
formoterol and budesonide; inhalant
2.0
14.2
199
1095
R03BA05
ATC
fluticasone; inhalant
2.0
14.2
195
1063
A02BC02
ATC
pantoprazole; systemic
1.7
14.2
607
4774
Z3229
NOMESCO Finland
Other healthcare associate professional
2.7
14.1
104
419
G44.2
ICD-10 Finland
Tension-type headache
2.2
13.9
151
744
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
2.7
13.7
100
402
J01CA04
ATC
amoxicillin; systemic
1.8
13.7
810
6982
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.7
13.6
360
2457
J45.1
ICD-10 Finland
Nonallergic asthma
2.9
13.5
86
317
M03BC51
ATC
orphenadrine, combinations; systemic
1.8
13.5
280
1769
J01FA09
ATC
clarithromycin; systemic
1.8
13.4
319
2108
ZXA10
NOMESCO Finland
Bilateral
2.0
13.2
193
1077
TCC10
NOMESCO Finland
Probing of lacrimal canaliculus/duct
12.4
13.1
23
19
N05BB01
ATC
hydroxyzine; systemic
3.0
13.1
79
280
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
2.3
13.1
133
636
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.6
13.1
98
399
L71.8
ICD-10 Finland
Other rosacea
7.1
12.9
31
45
F03
ICPC
Eye discharge
2.9
12.8
78
281
M01AE03
ATC
ketoprofen; systemic, rectal
1.7
12.6
343
2345
J02AC01
ATC
fluconazole; systemic
1.7
12.5
416
3012
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.4
12.5
114
515
R05
ICD-10 Finland
Cough
1.9
12.3
197
1133
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
3.8
12.2
51
139
S01BC05
ATC
ketorolac; ophthalmic
3.8
12.2
51
139
WX002
NOMESCO Finland
Sedation and analgesia
1.9
12.1
192
1101
R42
ICD-10 Finland
Dizziness and giddiness
1.9
12.1
209
1237
H57.1
ICD-10 Finland
Ocular pain
3.9
12.0
48
126
D07BA04
ATC
hydrocortisone and antiseptics; topical
2.3
12.0
111
507
T78.4
ICD-10 Finland
Allergy, unspecified
3.3
12.0
61
195
R21
ICPC
Throat symptom/complaint
1.9
11.8
208
1236
H11.0
ICD-10 Finland
Pterygium
65.7
11.6
13
*
J30.0
ICD-10 Finland
Vasomotor rhinitis
4.8
11.6
38
82
R53
ICD-10 Finland
Malaise and fatigue
1.9
11.6
196
1150
H11.3
ICD-10 Finland
Conjunctival haemorrhage
4.9
11.6
37
78
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
3.1
11.5
62
206
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.2
11.5
129
643
N06AX11
ATC
mirtazapine; oral
1.7
11.5
294
1965
J01AA04
ATC
lymecycline; systemic
2.1
11.5
137
700
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.8
11.5
218
1328
H11.4
ICD-10 Finland
Other conjunctival vascular disorders and cysts
121.3
11.4
12
*
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
1.8
11.3
204
1222
H02AB04
ATC
methylprednisolone; systemic
2.0
11.3
148
789
Z51.6
ICD-10 Finland
Desensitization to allergens
9.0
11.3
23
26
R01BA52
ATC
pseudoephedrine, combinations; oral
1.7
11.3
296
1991
N06AX16
ATC
venlafaxine; oral
2.1
11.2
138
717
J05AB01
ATC
aciclovir; systemic
1.8
11.1
210
1278
J01DA06
ATC
[U] cefuroxime; systemic
2.0
11.0
153
831
A02BA02
ATC
ranitidine; systemic
1.9
11.0
178
1027
A02BC03
ATC
lansoprazole; oral
1.7
10.9
264
1733
Z58.8
ICD-10 Finland
Other problems related to physical environment
43.8
10.9
13
*
L20
ICD-10 Finland
Atopic dermatitis
4.3
10.9
40
97
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.4
10.9
91
394
S01AA02
ATC
chlortetracycline; ophthalmic
12.1
10.9
19
16
R01AC02
ATC
levocabastine; nasal
4.6
10.7
36
80
UDH02
NOMESCO Finland
Rhinopharyngoscopy
2.7
10.7
74
289
CF2S4
NOMESCO Finland
Photography of conjunctiva
60.6
10.6
12
*
CG2T4
NOMESCO Finland
Topography assessment of cornea
11.4
10.6
19
17
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.0
10.4
60
209
J01MA02
ATC
ciprofloxacin; systemic
1.6
10.4
337
2394
M35.0
ICD-10 Finland
Sicca syndrome [Sjögren]
4.6
10.3
35
79
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.7
10.3
223
1411
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.7
10.3
229
1464
D11AH02
ATC
pimecrolimus; topical
23.6
10.3
14
6
S01EE05
ATC
tafluprost; ophthalmic
3.9
10.2
41
109
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.2
10.2
104
497
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
10.1
499
3915
R51.80
ICD-10 Finland
Headache
1.9
10.0
151
847
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.9
10.0
165
956
D07CA01
ATC
hydrocortisone and antibiotics; topical
2.0
10.0
134
720
CBB30
NOMESCO Finland
Excision of lesion of eyelid
4.2
9.8
36
88
J02AC02
ATC
itraconazole; systemic
1.8
9.8
180
1079
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.6
9.8
294
2037
H10.8
ICD-10 Finland
Other conjunctivitis
10.8
9.8
18
17
E000006
ATC
NA
2.4
9.8
81
348
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
2.3
9.7
91
416
M53.1
ICD-10 Finland
Cervicobrachial syndrome
2.1
9.7
112
567
D06BX01
ATC
metronidazole; topical
2.1
9.6
109
545
S01ED01
ATC
timolol; ophthalmic
3.5
9.6
44
131
N02BE01
ATC
paracetamol; systemic, rectal
1.7
9.6
802
7099
F02
ICPC
Red eye
3.0
9.6
54
184
D07XC01
ATC
betamethasone, combinations; topical
2.1
9.5
110
555
H16.8
ICD-10 Finland
Other keratitis
30.3
9.4
12
*
L01
ICPC
Neck symptom/complaint
1.9
9.4
139
774
H16.4
ICD-10 Finland
Corneal neovascularization
+∞
9.4
9
*
P01AB01
ATC
metronidazole; oral, rectal
1.5
9.4
376
2799
N06AB04
ATC
citalopram; systemic
1.7
9.3
207
1316
D07CC01
ATC
betamethasone and antibiotics; topical
2.0
9.3
123
656
R96
ICPC
Asthma
2.3
9.2
86
394
R74
ICPC
Upper respiratory infection acute
1.6
9.2
280
1947
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.0
9.1
118
623
D02AX
ATC
Other emollients and protectives
3.3
9.1
45
142
J45.8
ICD-10 Finland
Mixed asthma
3.8
9.1
37
100
CG2S4
NOMESCO Finland
Photography of cornea
15.7
9.0
14
9
F01
ICPC
Eye pain
3.7
9.0
38
106
U02
ICPC
Urinary frequency/urgency
1.9
9.0
129
711
M79.6
ICD-10 Finland
Pain in limb
1.6
9.0
323
2334
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.2
9.0
94
456
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
9.0
262
1800
Z71.8
ICD-10 Finland
Other specified counselling
1.7
8.9
224
1474
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
3.4
8.9
42
128
S01AA12
ATC
tobramycin; ophthalmic
24.2
8.9
12
5
R03BA01
ATC
beclometasone; inhalant
1.9
8.9
133
742
NF1AE
NOMESCO Finland
Hip joint ultrasound examination
3.8
8.8
36
98
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
8.8
150
877
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
2.1
8.8
99
496
M01AH05
ATC
etoricoxib; oral
1.5
8.7
538
4380
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
2.5
8.7
66
272
F71
ICPC
Conjunctivitis allergic
50.4
8.7
10
*
ZXC60
NOMESCO Finland
Application of heat
5.1
8.7
26
52
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.7
8.7
207
1345
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.9
8.6
124
685
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
8.3
8.6
18
22
D31.0
ICD-10 Finland
Benign neoplasm: Conjunctiva
11.7
8.6
15
13
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.9
8.6
124
686
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
2.2
8.6
86
407
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.5
8.6
406
3121
L04AX01
ATC
azathioprine; systemic
2.7
8.5
55
208
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
2.3
8.5
76
343
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
3.2
8.4
43
140
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.7
8.4
203
1323
CGE55
NOMESCO Finland
Excision of pterygium with transplanation of conjunctiva
+∞
8.3
8
*
J01FF01
ATC
clindamycin; systemic
1.6
8.3
242
1654
A07AA02
ATC
nystatin; oral
2.5
8.3
63
260
R03AK08
ATC
formoterol and beclometasone; inhalant
3.2
8.3
42
136
A01AB04
ATC
amphotericin B; local oral
2.7
8.2
53
200
M54.5
ICD-10 Finland
Low back pain
1.5
8.2
295
2125
N06AX21
ATC
duloxetine; oral
2.0
8.2
111
596
S18
ICPC
Laceration/cut
1.5
8.2
364
2750
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.7
8.2
55
211
H00.1
ICD-10 Finland
Chalazion
3.1
8.1
43
144
J30.1
ICD-10 Finland
Allergic rhinitis due to pollen
33.6
8.1
10
*
H01.1
ICD-10 Finland
Noninfectious dermatoses of eyelid
9.0
8.1
16
18
N05CF01
ATC
zopiclone; oral
1.6
8.0
275
1956
A11
ICPC
Chest pain NOS
2.4
8.0
67
292
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
3.0
8.0
43
146
M02AA07
ATC
piroxicam; topical
1.5
7.9
312
2291
R03BA08
ATC
ciclesonide; inhalant
2.2
7.9
84
407
R05
ICPC
Cough
1.6
7.9
207
1372
L03
ICPC
Low back symptom/complaint
1.6
7.9
220
1486
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
2.9
7.9
46
163
D23.1
ICD-10 Finland
Benign neoplasm: Skin of eyelid, including canthus
3.3
7.8
37
114
F45.8
ICD-10 Finland
Other somatoform disorders
2.3
7.8
72
330
D02AE01
ATC
carbamide; topical
2.3
7.8
67
297
E000007
ATC
NA
2.6
7.8
55
220
S01EC04
ATC
brinzolamide; ophthalmic
3.3
7.8
38
120
H15.1
ICD-10 Finland
Episcleritis
5.1
7.7
23
46
F51.0
ICD-10 Finland
Nonorganic insomnia
1.9
7.7
121
688
WX110
NOMESCO Finland
Local anesthesy
1.5
7.7
646
5539
D11AX15
ATC
[U] pimecrolimus; topical
45.3
7.7
9
*
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.5
7.7
507
4143
H10.2
ICD-10 Finland
Other acute conjunctivitis
5.6
7.7
21
38
S29
ICPC
Skin symptom/complaint other
1.8
7.7
149
908
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.0
7.6
99
523
6918B
ICD-9 Finland
Atopic dermatitis and related conditions, Other atopic dermatitis and related conditions[ECZEMA ATOPICUM]
6.8
7.6
18
27
69100
ICD-8 Finland
Infantile eczema and related conditions, Eczema atopicum. Prurigo Besnier. Eczema pruriginosum allergicum
5.2
7.6
22
43
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.7
7.4
147
901
R06.5
ICD-10 Finland
Mouth breathing
2.1
7.4
81
400
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.8
7.4
134
799
N03AX12
ATC
gabapentin; oral
1.8
7.4
141
854
KMAK
NOMESCO Finland
NA
1.4
7.3
476
3864
A01AB09
ATC
miconazole; local oral
2.0
7.3
86
439
114
Kela drug reimbursment
Glaucoma
2.1
7.3
77
374
R03AC13
ATC
formoterol; inhalant
2.6
7.3
51
204
M01AH01
ATC
celecoxib; oral (coxibs)
1.7
7.2
162
1031
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.6
7.2
238
1672
N95
ICPC
Tension headache
20.2
7.1
10
5
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
6.6
7.1
17
26
S01ED02
ATC
betaxolol; ophthalmic
8.0
7.1
15
19
CD2S4
NOMESCO Finland
Photography of eye
8.0
7.1
15
19
K04
ICPC
Palpitations/awareness of heart
2.5
7.1
54
226
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
2.8
7.1
43
158
E000003
ATC
NA
2.6
7.0
49
194
R50.9
ICD-10 Finland
Fever, unspecified
1.7
7.0
135
819
R49.01
ICD-10 Finland
Functional dysphonia
3.3
7.0
33
102
H19.1*B00.5
ICD-10 Finland
Herpesviral keratoconjunctivitis
7.0
7.0
16
23
R03BB01
ATC
ipratropium bromide; inhalant
3.1
7.0
36
119
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.8
7.0
128
764
L04
ICPC
Chest symptom/complaint
2.4
7.0
55
234
R03BB04
ATC
tiotropium bromide; inhalant
2.0
6.9
80
407
H18.5
ICD-10 Finland
Hereditary corneal dystrophies
7.6
6.9
15
20
R01AD11
ATC
triamcinolone; nasal
2.0
6.9
84
436
N06AB03
ATC
fluoxetine; oral
1.8
6.9
119
698
D01
ICPC
Abdominal pain/cramps general
1.9
6.9
107
607
J30.4
ICD-10 Finland
Allergic rhinitis, unspecified
2.9
6.9
40
142
R02
ICPC
Shortness of breath/dyspnoea
1.9
6.9
101
562
H40.9
ICD-10 Finland
Glaucoma, unspecified
4.9
6.9
21
44
S01ED51
ATC
timolol, combinations; ophthalmic
2.2
6.9
65
302
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.1
6.8
74
363
N05BA04
ATC
oxazepam; oral
1.6
6.8
215
1491
UKC02
NOMESCO Finland
Cystoscopy
1.8
6.8
113
656
R35
ICD-10 Finland
Polyuria
2.4
6.8
54
231
R05FB02
ATC
cough suppressants and expectorants
1.5
6.8
325
2473
M03BC01
ATC
orphenadrine (citrate); systemic
1.6
6.8
216
1504
A01
ICPC
Pain general/multiple sites
2.1
6.7
74
368
J01DC02
ATC
cefuroxime; systemic
2.3
6.7
60
273
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
2.2
6.7
67
320
M48.0
ICD-10 Finland
Spinal stenosis
1.9
6.7
103
584
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
3.0
6.6
35
118
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
3.6
6.6
28
80
H18.8
ICD-10 Finland
Other specified disorders of cornea
7.9
6.6
14
18
CB9S4
NOMESCO Finland
Photography of eyelids and eyebrows
12.3
6.6
11
9
M01AE02
ATC
naproxen; oral, rectal
1.4
6.6
519
4337
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
2.1
6.6
73
366
R07.0
ICD-10 Finland
Pain in throat
2.2
6.5
61
283
A04
ICPC
Weakness/tiredness general
1.8
6.5
114
675
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.6
6.5
205
1424
S01CA03
ATC
hydrocortisone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
6.2
6.5
16
26
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.3
6.5
55
244
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.0
6.5
84
445
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.3
6.4
57
256
R13
ICD-10 Finland
Dysphagia
2.3
6.4
57
256
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.8
6.4
101
574
H02.0
ICD-10 Finland
Entropion and trichiasis of eyelid
4.1
6.4
23
57
K59.0
ICD-10 Finland
Constipation
2.4
6.4
54
236
ZXD05
NOMESCO Finland
Urgent procedure
1.5
6.4
272
2017
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.6
6.4
43
169
L04AA06
ATC
mycophenolic acid; systemic
3.8
6.4
25
67
K07.60
ICD-10 Finland
Snapping jaw
2.3
6.4
54
238
S21
ICPC
Skin texture symptom/complaint
1.8
6.3
109
638
H02.1
ICD-10 Finland
Ectropion of eyelid
6.6
6.3
15
23
A92
ICPC
Allergy/allergic reaction NOS
3.3
6.3
30
94
A46
ICD-10 Finland
Erysipelas
1.8
6.3
107
622
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
3.3
6.3
29
89
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.9
6.3
91
505
R05FA02
ATC
opium derivatives and expectorants; systemic
1.4
6.3
360
2831
CFD10
NOMESCO Finland
Repair of conjunctiva
+∞
6.3
6
*
H03.1*B08.1
ICD-10 Finland
Involvement of eyelid in molluscum contagiosum
+∞
6.3
6
*
R03CC02
ATC
salbutamol; systemic
2.2
6.2
61
288
F13
ICPC
Eye sensation abnormal
3.1
6.2
31
101
WX140
NOMESCO Finland
Parabulbar anesthesy
2.7
6.2
38
142
H01
ICPC
Ear pain/earache
1.8
6.2
106
621
R4120
NOMESCO Finland
Occupational therapy
2.1
6.2
65
316
H02.3
ICD-10 Finland
Blepharochalasis
2.2
6.2
58
269
H40.5
ICD-10 Finland
Glaucoma secondary to other eye disorders
6.3
6.2
15
24
R01AC01
ATC
cromoglicic acid; nasal
2.8
6.2
37
136
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
6.2
361
2847
R06.2
ICD-10 Finland
Wheezing
2.5
6.1
45
186
H40.0
ICD-10 Finland
Glaucoma suspect
2.1
6.1
67
331
M01AG02
ATC
tolfenamic acid; oral, rectal
1.6
6.1
147
949
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
1.9
6.1
91
506
K30
ICD-10 Finland
Functional dyspepsia
1.8
6.1
95
539
L13
ICPC
Hip symptom/complaint
1.7
6.1
133
835
F43.8
ICD-10 Finland
Other reactions to severe stress
3.6
6.1
25
70
S01BA07
ATC
fluorometholone; ophthalmic (corticosteroids, plain)
4.1
6.1
22
55
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.6
6.1
43
172
S01AA13
ATC
fusidic acid; ophthalmic
3.0
6.1
32
109
D18
ICPC
Change in faeces/bowel movements
3.6
6.0
25
71
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.2
6.0
57
266
Z50.1
ICD-10 Finland
Other physical therapy
2.4
6.0
49
213

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
258
1010
3.01
47.95
2.2
1.6
—
—
—
0
0
(3001604) Monocytes [#/volume] in Blood
680
4625
2.18
34.83
7.8
6.0
e9/l
0.6
0.6
0.43
592
4028
(3013115) Eosinophils [#/volume] in Blood
698
4801
2.19
34.67
8.2
6.3
e9/l
0.2
0.2
1.28
619
4248
(3006315) Basophils [#/volume] in Blood
681
4644
2.18
34.52
7.8
6.0
e9/l
0.0
0.0
1.47
593
4047
(3019198) Lymphocytes [#/volume] in Blood
690
4760
2.16
33.54
7.8
6.0
e9/l
2.0
2.0
0.03
609
4231
(3013650) Neutrophils [#/volume] in Blood by Automated count
741
5399
2.08
29.29
10.4
9.3
e9/l
4.0
4.0
0.16
651
4735
(3033658) Prothrombin time (PT) actual/Normal
386
2236
2.10
28.65
4.4
3.8
%
94.3
92.7
0.59
379
2174
(3037522) Nuclear Ab [Titer] in Serum
256
1260
2.33
28.49
1.5
1.3
titre
525.7
518.9
0.02
63
261
(40758558) Short blood count panel - Blood
404
2389
2.08
28.31
7.8
6.8
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
362
2096
2.07
26.53
4.5
3.7
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
485
3118
1.97
26.44
4.6
3.7
e6/l
78.0
98.2
0.24
332
2167
(42870588) Differential panel, method unspecified - Blood
479
3102
1.95
25.25
7.6
6.1
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
546
3717
1.91
24.53
5.0
4.7
g/l
36.2
35.9
0.93
507
3474
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
284
1549
2.11
24.08
2.7
2.9
mmol/l
2.4
2.5
1.14
230
1376
(3022096) Basophils/100 leukocytes in Blood
599
4224
1.89
23.93
7.9
6.2
%
0.7
0.7
2.34
574
3950
(3006504) Eosinophils/100 leukocytes in Blood
613
4362
1.89
23.73
7.9
6.1
%
2.9
2.9
0.25
588
4075
(3018010) Neutrophils/100 leukocytes in Blood
622
4450
1.89
23.64
7.7
6.0
%
56.4
56.3
0.02
598
4176
(3013707) Erythrocyte sedimentation rate by Westergren method
856
6819
2.06
23.42
5.3
4.1
mm/h
11.0
11.7
0.89
818
6309
(3019069) Monocytes/100 leukocytes in Blood
613
4382
1.87
23.19
8.1
6.4
%
8.4
8.4
0.12
589
4118
(36304419) Bacteria [Presence] in Urine
381
2347
1.94
22.77
4.1
3.0
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
264
1431
2.10
22.59
3.3
2.7
e6/l
0.7
1.2
2.73
149
815
(3002030) Lymphocytes/100 leukocytes in Blood
624
4510
1.86
22.54
7.9
6.2
%
28.6
29.0
0.34
600
4218
(3015171) Extractable nuclear Ab [Units/volume] in Serum
100
350
3.04
21.89
1.3
1.2
u/ml
0.2
1.2
—
9
33
(3007164) IgA [Mass/volume] in Serum or Plasma
323
1926
1.95
20.96
1.6
1.5
g/l
2.3
2.3
0.02
185
1168
(3030467) Casts [#/volume] in Urine by Automated count
377
2378
1.88
20.55
4.1
3.1
e6/l
0.2
0.5
2.05
294
1792
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
564
4032
1.80
20.34
7.6
6.0
mmol/l
1.2
1.2
0.21
528
3651
(3015377) Calcium [Moles/volume] in Serum or Plasma
452
3035
1.82
20.03
3.5
3.4
mmol/l
2.4
2.4
0.08
391
2675
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
497
3445
1.79
19.70
2.2
1.9
pmol/l
99.0
96.0
0.74
266
1770
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
401
2608
1.83
19.64
2.4
2.1
u/l
137.1
230.6
1.66
379
2461
(3005322) IgE [Units/volume] in Serum or Plasma
141
623
2.44
19.56
1.6
1.2
u/ml
451.3
205.5
1.14
132
570
(3000494) Fungus identified in Specimen by Culture
204
1056
2.14
19.43
1.9
1.5
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
759
5992
1.81
18.93
5.8
4.3
e6/l
12.9
3011.7
—
10
83
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
539
3877
1.75
18.40
2.7
2.4
nmol/l
79.7
76.7
1.55
501
3506
(3018418) pH of Serum or Plasma
394
2597
1.79
18.16
5.0
3.8
ph
7.4
7.4
0.79
42
500
(3026493) Urate [Moles/volume] in Serum or Plasma
348
2217
1.82
17.92
2.5
2.6
umol/l
1906.4
5602.9
1.32
304
1934
(40768804) Tissue Pathology biopsy report
515
3701
1.72
17.29
2.4
2.0
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
390
2604
1.76
16.95
4.1
3.2
e6/l
42.2
75.8
0.60
304
2001
(4010399)
138
649
2.28
16.54
1.7
1.4
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
291
1797
1.83
16.36
3.1
2.5
e6/l
4.6
6.9
2.60
263
1580
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
587
4438
1.67
15.79
8.4
6.6
mmol/l
1.2
1.2
0.25
537
3751
(3028433) Virus identified in Specimen by Culture
23
32
7.32
15.71
1.5
1.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
144
707
2.19
15.51
3.3
2.8
g/l
9.7
10.2
1.00
139
650
(3000492) Spirometry study
169
883
2.07
15.50
1.9
1.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
546
4088
1.65
14.97
3.1
2.7
ug/l
124.5
111.4
0.35
521
3790
(3003888) Timothy IgE Ab [Units/volume] in Serum
57
182
3.25
14.56
1.1
1.1
u/ml
5.0
6.2
0.29
47
97
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
154
804
2.06
14.10
2.7
2.2
u/l
122.8
38.6
0.47
138
673
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
226
1346
1.85
14.05
3.5
2.9
e6/l
2.0
3.0
0.96
111
737
(3021589) Normoblasts [#/volume] in Blood
549
4159
1.62
14.05
9.2
9.2
e9/l
0.0
0.0
0.26
437
3412
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
867
7382
1.75
13.89
5.0
4.0
pmol/l
14.6
14.7
0.74
816
6742
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
833
7037
1.70
13.47
8.4
7.2
u/l
80.9
80.2
0.14
798
6614
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1036
9380
2.27
13.26
18.1
12.8
mg/l
21.8
22.3
0.18
832
7257
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
53
175
3.13
12.83
1.3
1.4
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
53
175
3.13
12.83
1.3
1.4
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
116
564
2.18
12.75
1.8
1.8
g/l
1.0
1.3
1.50
108
522
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
258
1645
1.74
12.61
1.4
1.3
iu/ml
18.4
31.4
2.31
77
534
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
123
615
2.12
12.59
2.4
2.4
au/ml
36.3
24.1
—
8
37
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
974
8661
1.91
12.56
6.1
4.8
mu/l
1.8
1.9
2.08
917
7963
(3003338) MCHC [Mass/volume]
928
8134
1.79
12.50
23.8
16.6
g/l
332.4
332.4
0.10
923
8071
(36660697) Celiac disease serology panel - Serum
145
776
2.00
12.35
1.2
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
83
355
2.44
12.29
1.6
1.2
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
51
175
3.00
11.58
1.1
1.1
u/ml
2.7
2.4
0.06
38
86
(3009261) Glucose [Presence] in Urine by Test strip
580
4580
1.55
11.57
4.6
3.7
estimate
0.0
0.0
0.80
64
815
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
323
2236
1.62
11.39
1.4
1.3
u/ml
1.2
1.6
0.30
74
592
(3009445) Proteinase 3 Ab [Units/volume] in Serum
81
356
2.37
11.31
2.0
1.5
u/ml
18.9
8.9
—
5
8
(3035350) Ketones [Presence] in Urine by Test strip
570
4504
1.54
11.20
4.6
3.6
estimate
0.0
0.0
0.00
64
834
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
313
2159
1.62
11.17
2.3
2.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
573
4535
1.54
11.16
6.1
4.9
estimate
0.0
0.0
0.50
66
838
(3026782) Osmolality of Urine
260
1716
1.67
11.03
3.2
2.8
mosm/kgh2o
533.8
550.9
0.59
228
1457
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
55
204
2.78
10.86
1.1
1.1
u/ml
2.8
2.9
0.01
38
95
(3048689) Calprotectin [Mass/mass] in Stool
200
1235
1.75
10.81
2.5
2.4
ug/g
116.3
127.8
0.16
147
977
(3017143) Hepatitis C virus Ab [Presence] in Serum
179
1075
1.79
10.63
1.9
1.5
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
241
1574
1.68
10.60
1.4
1.3
u/ml
4.1
13.9
3.40
68
627
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
68
285
2.47
10.54
1.6
1.6
—
161.7
—
0
12
(40761535) Cells panel - Urine sediment
129
700
1.95
10.52
4.8
3.5
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
748
6316
1.55
10.50
5.4
4.2
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
199
1239
1.74
10.42
1.9
2.0
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
84
391
2.24
10.27
2.3
2.1
u/l
40.6
39.6
0.22
76
344
(3010726) Horse dander IgE Ab [Units/volume] in Serum
48
176
2.80
9.71
1.1
1.1
u/ml
3.2
3.0
—
10
53
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
582
4724
1.48
9.40
5.9
6.1
umol/l
11.3
11.5
0.13
561
4482
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
21
45
4.74
9.32
2.0
3.2
u/ml
946.2
900.1
0.04
21
45
(3044640) Blood type and Crossmatch panel - Blood
381
2846
1.51
9.25
2.5
2.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
315
2259
1.55
9.25
5.0
4.1
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
955
8628
1.69
9.24
14.7
11.6
ml/min/173m2
84.2
83.3
0.61
784
7030
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
290
2042
1.57
9.23
1.9
1.8
mg/l
1.0
1.1
0.32
232
1552
(46235355) HIV 1 and 2 tests - Meaningful Use set
253
1726
1.60
9.22
2.2
1.8
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
217
1430
1.64
9.10
1.8
1.6
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
213
1400
1.64
9.02
4.2
3.9
mmol/l
0.8
0.8
0.05
202
1308
(3019550) Sodium [Moles/volume] in Serum or Plasma
1028
9509
1.91
8.86
19.6
14.4
mmol/l
139.5
139.7
1.35
1011
9264
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
269
1880
1.57
8.80
1.8
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
893
7970
1.58
8.68
20.8
15.7
%
13.6
13.6
0.03
882
7792
(3003327) Ova and parasites identified in Stool by Light microscopy
68
312
2.26
8.63
1.9
1.7
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
16
29
5.58
8.51
1.1
1.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
1029
9541
1.89
8.51
19.9
14.5
mmol/l
3.9
4.0
2.30
1008
9279
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
14
23
6.15
8.19
1.3
1.1
%
70.4
91.0
1.47
14
23
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
14
23
6.15
8.19
1.3
1.1
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
32
103
3.17
8.15
1.1
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
55
237
2.39
8.07
1.3
1.2
u/ml
10.1
8.9
—
10
40
(3004588) Protein electrophoresis panel - Serum or Plasma
99
538
1.92
8.03
1.9
2.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
58
258
2.32
7.93
1.7
1.3
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
54
233
2.38
7.91
1.3
1.2
u/ml
3.0
2.8
—
7
23
(40768797) Stomach Pathology biopsy report
188
1237
1.62
7.86
1.3
1.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1050
9842
1.96
7.77
14.3
12.0
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
118
686
1.80
7.75
2.7
2.3
ug/l
4.0
7.2
3.37
100
611
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
60
276
2.24
7.60
2.3
2.2
g/l
3.0
3.2
0.80
50
211
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
63
299
2.17
7.40
1.9
1.8
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
116
682
1.78
7.34
1.6
1.4
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
58
267
2.24
7.34
2.3
2.2
g/l
9.8
10.6
0.91
49
222
(3022948) Iron [Moles/volume] in Serum or Plasma
199
1349
1.58
7.32
2.2
2.3
umol/l
14.8
13.3
1.83
188
1242
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
296
2187
1.48
7.29
2.3
2.2
mg/l
2.7
3.0
1.87
267
1871
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
61
288
2.18
7.26
2.2
2.2
g/l
3.8
3.7
0.08
47
205
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
53
236
2.31
7.25
2.7
2.8
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
61
289
2.17
7.20
2.2
2.2
g/l
7.2
7.5
0.79
51
217
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
61
289
2.17
7.20
2.2
2.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
734
6393
1.42
7.18
3.7
3.1
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
106
612
1.81
7.13
1.8
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
59
278
2.18
7.06
1.3
1.2
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
108
629
1.79
7.06
1.3
1.2
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
273
1997
1.48
7.04
5.2
4.0
kg/l
1.0
1.0
0.59
32
305
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
39
153
2.60
6.99
1.4
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
58
275
2.17
6.84
1.3
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
37
143
2.64
6.84
1.5
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
108
635
1.77
6.84
2.3
1.9
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
159
1038
1.62
6.83
2.8
3.0
umol/l
6.7
8.6
0.88
141
898
(3019309) Folate [Moles/volume] in Red Blood Cells
214
1497
1.53
6.81
1.7
1.7
nmol/l
1165.1
1214.2
0.37
172
1127
(3036481) Cortisol [Moles/volume] in Serum or Plasma
142
903
1.65
6.77
2.4
2.0
nmol/l
379.9
367.7
0.30
130
835
(42529406) Shigella sp [Presence] in Stool by Culture
59
283
2.14
6.77
1.3
1.2
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
191
1317
1.54
6.48
2.4
2.2
s
28.4
29.6
3.35
184
1279
(4062490)
26
86
3.07
6.37
1.7
1.3
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
225
1617
1.49
6.26
3.7
3.6
ng/l
214.7
458.8
1.45
164
1186
(3021960) Folate [Moles/volume] in Serum or Plasma
264
1959
1.45
6.24
1.6
1.5
nmol/l
22.0
21.0
0.50
239
1665
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
113
695
1.70
6.11
3.8
4.0
ng/l
74.3
77.7
0.24
105
616
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
55
268
2.11
6.08
3.2
3.2
g/l
3.4
3.4
0.10
50
256
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
145
953
1.60
6.05
1.9
1.8
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
23
73
3.20
6.04
3.5
1.9
e6/l
679.1
747.9
—
10
22
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1050
9953
1.79
5.87
13.1
9.9
u/l
26.9
26.0
0.60
1029
9620
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
38
161
2.41
5.85
1.5
1.6
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
53
260
2.09
5.77
3.9
3.2
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
948
8783
1.50
5.72
20.2
13.8
%
39.8
39.7
0.26
762
6500
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
303
2344
1.40
5.62
2.9
3.1
ng/l
1080.4
1078.6
0.00
256
1953
(3004789) Transferrin [Mass/volume] in Serum or Plasma
175
1220
1.51
5.61
2.3
2.3
g/l
2.4
2.4
0.03
169
1133
(3026389) Candida sp identified in Specimen by Organism specific culture
29
111
2.66
5.51
1.3
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
86
505
1.76
5.50
2.0
1.7
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
159
1091
1.53
5.49
8.2
6.4
—
—
—
0
0
(3044889) 12 lead EKG panel
715
6340
1.35
5.39
4.4
3.5
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
164
1140
1.51
5.33
2.5
2.4
%
24.9
23.1
0.80
153
975
(3034860) Kappa light chains.free [Mass/volume] in Serum
47
228
2.11
5.29
2.5
3.9
mg/l
63.9
75.3
0.14
40
178
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
47
228
2.11
5.29
2.5
3.9
mg/l
27.2
44.5
0.66
40
178
(3011412) CD3 cells [#/volume] in Blood
26
96
2.75
5.29
3.3
2.5
e9/l
1.3
1.1
0.25
13
61
(21494815) CD4 cells/100 lymphocytes in Specimen
24
85
2.86
5.27
2.2
2.3
%
35.8
39.7
—
6
6
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
163
1135
1.51
5.25
2.2
2.1
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
27
103
2.66
5.17
1.1
1.5
pmol/l
249.4
334.9
0.98
21
82
(3013826) Glucose [Moles/volume] in Serum or Plasma
603
5236
1.33
5.13
5.7
4.6
mmol/l
6.4
6.6
1.67
560
4881
(3019832) Treponema pallidum Ab [Presence] in Serum
137
926
1.55
5.06
1.7
1.6
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
82
490
1.73
4.95
8.6
9.1
%
94.8
94.3
0.38
82
485
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
21
72
2.95
4.89
1.2
1.0
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
20
67
3.02
4.84
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
20
67
3.02
4.84
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
20
67
3.02
4.84
1.2
1.2
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
85
518
1.69
4.79
1.4
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
138
946
1.52
4.78
1.9
1.7
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
20
68
2.98
4.73
1.2
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
20
68
2.98
4.73
1.2
1.2
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
20
68
2.98
4.73
1.2
1.2
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
165
1178
1.47
4.69
7.6
5.5
mmol/l
1.1
1.1
0.04
156
1090
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
53
282
1.92
4.67
1.8
1.6
iu/ml
0.7
0.1
0.42
12
58
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
123
827
1.55
4.66
2.1
2.5
g/l
0.2
0.2
0.68
111
782
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
699
6249
1.31
4.58
3.3
3.1
u/l
45.1
45.5
0.04
665
5861
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
23
88
2.65
4.41
1.2
1.1
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
373
3077
1.32
4.39
3.1
3.4
u/l
31.2
31.5
0.03
356
2930
(3037756) Immunofixation for Serum or Plasma
35
164
2.17
4.34
1.4
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
145
1025
1.48
4.34
2.1
2.0
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
78
478
1.68
4.32
7.8
5.3
mmol/l
23.7
24.0
0.39
71
437
(3044290) Cell count panel - Cerebral spinal fluid
39
193
2.06
4.22
2.2
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
109
732
1.54
4.16
9.9
8.3
—
—
—
0
0
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
125
865
1.50
4.15
2.4
4.1
ug/l
12.1
27.2
0.64
94
703
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
10
23
4.38
4.09
4.3
1.9
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
36
176
2.08
4.04
2.5
4.3
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
133
938
1.47
4.03
3.2
2.8
%
1.8
1.8
0.04
124
844
(3002256) Pathology report gross observation
157
1152
1.42
3.86
1.3
1.3
—
—
—
0
0
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
180
1354
1.39
3.84
2.1
1.8
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
23
96
2.42
3.74
1.3
1.7
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
74
466
1.63
3.73
1.7
1.6
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
95
635
1.54
3.72
2.4
3.0
ng/l
166.2
184.8
0.23
83
582
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
81
522
1.59
3.72
1.1
1.0
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
48
268
1.83
3.70
1.3
1.2
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
27
123
2.22
3.63
1.2
1.4
—
0.6
—
0
10
(3007461) Platelets [#/volume] in Blood
1087
10551
1.81
3.61
26.5
18.9
e9/l
258.1
256.5
0.31
1066
10282
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
15
51
2.97
3.58
1.0
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
56
332
1.72
3.55
1.4
1.3
miu/ml
244.5
236.2
0.06
27
161
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
222
1750
1.33
3.51
1.4
1.4
—
—
—
0
0
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
8
13
6.19
3.50
1.0
1.0
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
18
69
2.63
3.48
5.5
3.7
—
—
—
0
0
(3035941) MCH [Entitic mass]
1087
10559
1.79
3.48
26.4
18.8
pg
30.3
30.2
2.93
1078
10416
(3026361) Erythrocytes [#/volume] in Blood
1087
10560
1.79
3.46
26.5
18.9
e12/l
4.5
4.5
0.85
1061
10270
(3010813) Leukocytes [#/volume] in Blood
1087
10561
1.79
3.45
26.5
18.9
e9/l
6.7
6.7
0.37
1064
10265
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
946
8950
1.35
3.43
5.2
4.3
mmol/l
5.8
5.9
1.42
892
8180
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
30
147
2.07
3.38
1.0
1.0
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1087
10567
1.77
3.35
26.6
19.0
g/l
134.8
134.9
0.06
1078
10424
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
22
95
2.34
3.35
1.5
1.5
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
53
315
1.72
3.34
2.8
3.0
%
95.5
89.9
1.26
53
297
(3003396) Base excess in Arterial blood by calculation
125
904
1.43
3.34
7.3
7.9
mmol/l
1.2
1.2
0.07
100
714
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
24
108
2.25
3.33
1.3
1.4
nmol/l
—
—
—
0
0
(3024731) MCV [Entitic volume]
1086
10556
1.76
3.33
26.4
18.8
fl
91.0
90.5
2.95
1077
10414
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
48
278
1.76
3.31
1.4
1.3
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
125
908
1.42
3.26
7.3
7.9
kpa
12.9
12.6
0.22
118
872
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
125
908
1.42
3.26
7.3
7.9
kpa
5.0
5.1
0.55
119
872
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
18
72
2.52
3.22
1.0
1.3
u/ml
0.1
1.0
—
9
26
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
22
97
2.29
3.21
3.2
1.7
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
7
11
6.40
3.19
3.7
4.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
79
526
1.54
3.18
1.3
1.4
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
133
984
1.40
3.14
27.1
22.5
inr
1.2
1.3
—
10
136
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
9
20
4.53
3.11
1.1
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
137
1022
1.39
3.08
1.5
1.5
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
34
181
1.91
3.08
10.8
7.2
iu/ml
175.7
376.6
—
10
29
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
58
362
1.63
3.07
1.7
1.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
101
715
1.45
3.04
1.2
1.2
iu/ml
79.7
134.3
1.36
39
290
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
68
444
1.57
3.00
2.8
2.3
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
76
509
1.53
3.00
1.1
1.2
—
95.8
—
0
13
(3004616) Nuclear Ab [Presence] in Serum
23
107
2.17
2.98
1.2
1.2
—
—
—
0
0
(3022145) Colonoscopy Study observation
135
1012
1.38
2.95
1.3
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
145
1102
1.36
2.91
1.6
1.8
%
1.5
1.4
0.20
128
985
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
379
3266
1.24
2.91
4.2
3.4
ng/l
56.3
46.2
0.13
238
2127
(3000570) Elastase.pancreatic [Mass/mass] in Stool
45
267
1.71
2.89
1.3
1.5
ug/g
292.1
295.0
0.03
29
161
(1002224) Polysomnography panel
61
392
1.59
2.89
1.1
1.1
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
7
13
5.41
2.87
1.6
2.3
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
21
97
2.19
2.78
5.3
3.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
29
153
1.92
2.72
1.1
1.4
mmol/l
58.1
67.4
0.64
21
127
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
42
249
1.71
2.72
1.5
1.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
14
54
2.61
2.71
1.3
1.2
—
—
—
0
0
(3022313) Gas panel - Capillary blood
71
480
1.51
2.70
5.3
4.7
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
6
10
6.03
2.70
1.0
1.3
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
6
10
6.03
2.70
1.3
1.3
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
11
37
2.99
2.69
1.3
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
100
724
1.42
2.69
2.0
2.5
ml/min/173m2
67.0
69.0
0.22
38
305
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
484
4308
1.22
2.67
3.9
3.9
—
—
—
0
0
(3017704) Immunofixation for Urine
12
43
2.81
2.65
1.2
2.1
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
23
113
2.06
2.63
3.1
1.6
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
18
80
2.27
2.61
2.7
2.6
%
10.9
14.2
0.46
13
46
(3020874) Milk IgE Ab [Units/volume] in Serum
17
74
2.32
2.58
1.6
1.2
u/ml
83.0
1.9
0.88
11
30
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
20
94
2.15
2.55
1.2
1.1
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
331
2845
1.23
2.55
2.9
2.4
u/l
59.3
55.5
1.01
311
2625
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
85
605
1.44
2.52
2.5
3.2
pmol/l
4.2
4.6
4.61
78
524
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
34
195
1.77
2.49
1.9
1.5
—
—
—
0
0
(3048879) Bone marrow aspiration report
7
16
4.40
2.47
2.3
1.7
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
23
116
2.00
2.47
1.0
1.4
—
—
—
0
0
(3023430) Cat dander IgE Ab [Units/volume] in Serum
25
131
1.93
2.42
1.0
1.1
u/ml
6.8
5.3
0.15
15
56
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
18
83
2.19
2.42
3.9
3.8
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
24
124
1.96
2.41
1.3
3.2
umol/l
5.4
8.1
0.58
15
86
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
6
12
5.02
2.40
1.8
3.4
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
37
220
1.70
2.40
2.2
1.6
mmol/l
3.8
3.7
0.14
37
209
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
17
77
2.23
2.38
2.8
2.6
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
36
213
1.71
2.38
2.1
1.8
e6/l
505.2
1044.8
0.36
24
173
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
26
139
1.89
2.38
1.5
1.3
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
14
58
2.43
2.37
1.1
1.1
u/l
1.0
1.1
—
7
33
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
48
307
1.59
2.36
2.4
3.1
u/ml
14750.1
982.6
0.46
37
269
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
42
260
1.64
2.35
2.6
1.8
iu/l
3.2
5.2
0.67
16
90
(3023410) Appearance of Cerebral spinal fluid
21
105
2.02
2.32
2.9
2.0
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
21
105
2.02
2.32
1.7
1.4
mosm/kgh2o
288.6
279.4
1.26
16
78
(3008898) HLA-B27 [Presence]
54
357
1.54
2.31
1.1
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
14
59
2.39
2.30
1.5
1.5
u/l
10.7
9.0
—
7
28
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
51
334
1.55
2.28
1.9
1.7
g/l
1.6
1.5
0.10
46
294
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
16
72
2.24
2.28
2.6
2.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
19
92
2.08
2.28
1.4
1.3
—
—
—
0
0
(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma
34
202
1.70
2.23
2.5
3.4
u/ml
22.8
27.9
0.31
34
196
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
19
93
2.06
2.22
1.4
1.1
u/l
83.8
62.4
0.34
13
66
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
16
73
2.21
2.21
1.3
1.1
—
34.6
—
0
5
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
9
5.57
2.21
1.8
1.6
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
17
80
2.14
2.19
1.3
1.1
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
12
48
2.52
2.19
1.8
1.2
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
12
48
2.52
2.19
1.8
1.2
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
11
42
2.63
2.19
1.8
1.9
nmol/l
6.5
6.0
0.03
11
33
(3017817) Protein [Mass] in Urine collected for unspecified duration
15
67
2.26
2.18
1.5
2.7
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
282
2420
1.22
2.18
1.7
1.7
mmol/l
1.4
1.4
0.32
259
2036
(3029937) Albumin [Presence] in Urine by Test strip
283
2430
1.22
2.17
5.7
4.0
estimate
0.0
0.0
1.34
61
829
(3023419) Bacteria identified in Sputum by Culture
20
101
2.00
2.16
2.2
3.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
7
19
3.70
2.15
1.3
1.4
—
—
—
0
0
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
35
213
1.66
2.12
2.1
1.7
e6/l
14.7
14.1
0.02
23
171
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
22
116
1.91
2.12
1.0
1.1
u/ml
0.3
0.5
—
9
35
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
11
43
2.57
2.10
1.2
1.3
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
27
153
1.78
2.09
1.0
1.1
—
—
—
0
0
(3000012) Reticulocyte production index
0
56
0.00
2.06
0.0
1.8
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
296
3386
0.83
2.05
2.4
2.7
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
917
8784
1.23
2.04
4.4
3.8
mmol/l
1.4
1.3
1.81
867
8100
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
111
858
1.33
2.04
1.5
1.7
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
12
50
2.42
2.03
1.2
1.2
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
381
3387
1.19
2.00
8.1
8.2
inr
1.2
1.2
0.12
81
997
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
71
513
1.41
1.99
1.5
1.4
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
15
70
2.16
1.99
1.3
1.4
e6/l
1851.0
2077.9
—
9
49
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
39
249
1.59
1.97
1.4
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
28
164
1.73
1.96
2.7
1.8
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
73
532
1.40
1.95
1.6
1.7
—
—
—
0
0
(3009343) pH of Capillary blood
84
627
1.37
1.95
5.0
4.6
ph
7.4
7.4
—
6
71
(3017446) Testosterone [Moles/volume] in Serum or Plasma
70
508
1.40
1.92
2.5
2.3
nmol/l
12.0
12.5
0.19
63
452
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
10
39
2.58
1.92
1.8
1.2
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
10
39
2.58
1.92
1.8
1.2
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
965
9310
1.25
1.92
5.5
4.7
mmol/l
2.8
2.8
0.62
917
8616
(3024354) Oxygen [Partial pressure] in Venous blood
94
716
1.34
1.92
6.6
4.3
kpa
4.4
4.7
0.68
89
690
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
42
275
1.55
1.92
1.1
1.1
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
11
239
0.45
1.90
4.6
4.5
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
30
181
1.68
1.90
1.9
1.5
u/ml
127.8
116.0
—
6
30
(3028308) Erythrocytes [#/volume] in Pleural fluid
14
65
2.17
1.88
1.3
1.4
e6/l
225522.9
127324.4
—
7
40
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
9
34
2.66
1.86
1.1
1.2
ug/l
9.4
8.5
—
9
34
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
19
100
1.92
1.86
2.8
2.6
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
11
46
2.40
1.85
1.9
2.2
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
393
3523
1.18
1.85
4.9
3.8
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
81
607
1.36
1.84
5.1
4.7
mmol/l
2.3
1.7
0.42
58
452
(3006653) Thiamine [Moles/volume] in Blood
10
40
2.51
1.84
1.1
1.3
nmol/l
122.5
142.9
—
10
40
(3012441) Differential panel - Pleural fluid
14
66
2.14
1.82
1.2
1.4
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
40
263
1.54
1.81
3.0
2.5
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
12
53
2.28
1.81
4.5
2.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
945
9110
1.23
1.81
4.7
4.2
mmol/l
1.5
1.5
0.03
900
8426
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
9
35
2.58
1.80
1.2
1.1
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
246
2121
1.20
1.80
5.1
4.7
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
27
161
1.69
1.79
1.2
1.2
—
—
—
0
0
(3023520) Reticulocytes [#/volume] in Blood
89
681
1.33
1.78
2.6
2.8
e9/l
73.2
71.8
0.13
64
523
(3044941) Cell count panel - Synovial fluid
22
124
1.79
1.76
2.0
1.5
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
24
139
1.74
1.76
1.0
1.1
u/ml
8.8
4.4
0.43
13
59
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
53
372
1.45
1.76
1.5
1.8
mg/l
4.2
4.6
0.08
42
265
(3021447) Carbon dioxide [Partial pressure] in Venous blood
107
842
1.30
1.76
6.6
4.5
kpa
5.9
5.8
0.64
102
814
(21494434) Karyotype in Bone marrow
15
74
2.04
1.75
1.3
1.2
—
—
—
0
0
(44813793)
16
81
1.99
1.75
1.1
1.0
—
—
—
0
0
(4015189)
6
18
3.35
1.75
1.8
2.8
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
6
18
3.35
1.75
4.0
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
9
36
2.51
1.74
1.6
1.8
—
—
—
0
0
(3018405) Lactate [Moles/volume] in Arterial blood
43
291
1.50
1.72
2.8
3.9
mmol/l
1.1
1.4
1.93
43
284
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
948
9159
1.22
1.67
4.9
4.2
mmol/l
4.7
4.7
0.25
906
8530
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
6
19
3.17
1.66
1.7
2.5
umol/l
21.6
15.6
—
6
19
(3047189) Immunofixation for 24 hour Urine
8
31
2.59
1.66
1.3
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
59
800
0.72
1.65
6.4
3.6
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
15
76
1.99
1.64
1.7
1.8
—
—
—
0
0
(4024509)
15
76
1.99
1.64
1.3
1.4
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
52
719
0.71
1.64
4.9
4.2
%
0.6
0.5
0.06
20
162
(44790047)
21
120
1.76
1.63
1.6
1.6
—
—
—
0
0
(44790049)
21
120
1.76
1.63
1.6
1.6
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
21
120
1.76
1.63
2.4
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
21
120
1.76
1.63
2.4
1.4
—
—
—
0
0
(44806118)
21
120
1.76
1.63
1.6
1.6
—
—
—
0
0
(44790048)
21
120
1.76
1.63
1.6
1.6
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
5
14
3.58
1.61
1.2
1.1
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
5
14
3.58
1.61
2.6
2.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
21
121
1.75
1.59
2.4
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
21
121
1.75
1.59
2.4
1.4
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
24
144
1.68
1.58
1.7
1.6
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
20
3.01
1.58
1.2
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
32
207
1.56
1.58
1.4
1.5
—
—
—
0
0
(3020891) Body temperature
46
322
1.45
1.58
3.5
4.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
105
839
1.28
1.56
6.7
4.5
mmol/l
1.5
1.9
0.38
86
658
(3037121) Protein [Mass/volume] in Urine
46
323
1.44
1.55
2.8
4.1
g/l
0.4
0.2
0.69
18
143
(3024522) Salmonella sp identified in Specimen by Organism specific culture
21
122
1.73
1.55
2.4
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
21
122
1.73
1.55
2.4
1.4
—
—
—
0
0
(3011648) Oxygen content in Venous blood
13
64
2.04
1.54
12.7
7.9
%
9.6
11.5
0.82
13
64
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
10
44
2.28
1.53
1.5
1.2
—
—
—
0
0
(3013247) Albumin in CSF/Albumin in Serum or Plasma
5
15
3.34
1.52
1.4
1.0
mg/g
5.0
5.7
—
5
15
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
5
15
3.34
1.52
1.4
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
5
15
3.34
1.52
1.6
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
46
325
1.43
1.51
1.5
1.4
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
6
21
2.87
1.50
1.2
1.1
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
6
21
2.87
1.50
1.3
1.1
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
34
226
1.52
1.50
2.6
1.7
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
7
28
2.51
1.45
1.3
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
5
16
3.13
1.44
8.4
7.0
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
29
188
1.56
1.44
1.9
1.7
e6/l
9813.3
16962.0
0.43
20
143
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
59
2.05
1.44
1.3
1.2
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
22
2.74
1.43
1.2
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
9
39
2.32
1.43
1.4
1.8
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
40
2.26
1.40
1.6
1.2
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
9
40
2.26
1.40
1.0
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
14
74
1.90
1.39
1.0
1.3
—
—
—
0
0
(4027681)
11
53
2.09
1.38
1.3
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
22
135
1.64
1.36
1.4
1.7
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
8
164
0.48
1.36
1.5
1.5
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
17
2.95
1.36
1.6
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
30
199
1.52
1.36
1.4
1.4
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
23
143
1.62
1.36
1.6
1.8
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
32
216
1.50
1.34
1.6
1.3
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
10
47
2.14
1.34
1.9
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
30
200
1.51
1.33
1.4
1.4
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
53
702
0.74
1.32
4.6
4.4
%
0.0
0.6
0.64
21
171
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
869
8381
1.16
1.32
6.4
5.4
mmol/mol
38.8
39.5
1.38
825
7813
(3023323) Follitropin [Units/volume] in Serum or Plasma
67
518
1.31
1.30
1.4
1.4
iu/l
32.2
28.8
0.30
56
429
(3021440) Promyelocytes/100 leukocytes in Blood
57
745
0.75
1.30
4.9
4.4
%
0.3
0.1
0.40
23
207
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
35
243
1.45
1.29
1.4
1.4
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
5
18
2.79
1.28
1.0
1.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
52
388
1.36
1.28
2.0
1.8
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
10
48
2.09
1.28
1.0
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
10
48
2.09
1.28
1.0
1.0
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
8
35
2.29
1.27
1.0
1.3
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
22
138
1.61
1.27
1.2
1.1
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
35
244
1.45
1.27
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
35
244
1.45
1.27
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
35
244
1.45
1.27
1.4
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
61
786
0.76
1.26
4.9
4.3
%
0.8
1.0
0.22
24
227
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
8
36
2.23
1.24
1.0
1.1
iu/ml
146.5
197.8
—
8
36
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
9
45
2.01
1.23
1.3
1.4
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
9
45
2.01
1.23
2.7
6.7
—
44.5
—
0
13
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
12
63
1.91
1.23
1.2
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
12
63
1.91
1.23
1.3
1.2
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
11
56
1.97
1.22
3.9
7.4
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
19
116
1.65
1.22
2.0
2.4
mg/l
12.3
26.5
—
7
32
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
19
2.64
1.21
1.8
1.3
—
—
—
0
0
(3019060) Gas panel - Arterial blood
67
524
1.30
1.21
3.0
5.7
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
37
264
1.42
1.20
1.4
1.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
75
597
1.27
1.19
1.4
1.4
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
8
38
2.11
1.18
4.9
2.9
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
165
1.53
1.18
1.3
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
209
1844
1.16
1.18
1.5
1.7
pmol/l
436.7
30313333.8
2.04
176
1534
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
23
150
1.54
1.15
1.1
1.2
u/l
74.1
20.2
0.80
18
129
(3017732) Neutrophils [#/volume] in Blood
79
637
1.26
1.14
2.3
2.9
e9/l
4.3
3.9
0.57
63
514
(44816559) Phosphatidylethanol [Mass/volume] in Blood
27
183
1.49
1.14
1.4
1.2
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
7
30
2.34
1.12
2.7
2.6
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
30
2.34
1.12
1.3
1.2
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
23
151
1.53
1.12
1.5
1.2
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
10
51
1.97
1.11
1.0
1.0
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
34
243
1.41
1.10
2.4
3.8
u/ml
0.3
0.4
0.66
13
131
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
17
104
1.64
1.09
3.2
4.6
u/ml
17.2
104.7
—
7
30
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
28
194
1.45
1.07
1.8
1.6
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
13
217
0.59
1.06
1.4
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
32
228
1.42
1.06
2.6
1.7
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
29
203
1.44
1.06
2.2
1.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
58
732
0.78
1.05
6.1
3.7
mmol/l
1.2
1.2
0.71
52
632
(3000093) Morphology [Interpretation] in Blood Narrative
14
82
1.72
1.05
1.1
1.1
—
—
—
0
0
(4094501)
31
221
1.41
1.03
1.1
1.1
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
20
130
1.55
1.03
1.7
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
5
107
0.46
1.01
1.2
2.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
305
2792
1.13
1.01
3.7
3.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
25
172
1.46
1.00
10.4
4.8
—
—
—
0
0
(4268621)
16
99
1.63
1.00
2.4
2.3
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
89
741
1.22
0.99
10.8
7.6
mmol/l
8.5
8.4
0.04
82
703
(3045788) Cell count panel - Pleural fluid
11
61
1.81
0.98
1.4
1.4
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
227
2511
0.88
0.97
3.9
3.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
36
1.95
0.97
2.3
1.5
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
16
100
1.61
0.97
7.4
6.0
mmol/l
8.3
6.9
—
9
82
(3019897) Erythrocyte distribution width [Ratio] by Automated count
6
119
0.50
0.94
1.7
2.7
%
12.7
13.2
—
6
119
(40768806) Pleura Pathology biopsy report
12
70
1.72
0.92
1.2
1.6
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
12
70
1.72
0.92
1.0
1.2
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
34
452
0.74
0.92
3.1
3.5
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
49
384
1.29
0.92
1.5
1.4
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
6
28
2.15
0.91
6.0
3.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
40
305
1.32
0.91
1.3
1.4
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
18
118
1.53
0.91
1.3
1.7
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
14
86
1.64
0.91
1.3
1.2
—
—
—
0
0
(4035726)
95
804
1.20
0.91
1.5
1.4
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
6
29
2.07
0.89
1.0
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
10
169
0.59
0.88
1.0
1.1
—
125.2
—
0
45
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
12
193
0.62
0.88
1.9
1.7
—
—
—
0
0
(4211845)
8
43
1.87
0.87
5.0
2.7
—
—
—
0
0
(3019225) pH of Specimen
99
845
1.19
0.87
5.4
3.7
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
6
30
2.01
0.87
1.7
1.2
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
30
2.01
0.87
1.2
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
30
2.01
0.87
1.0
1.3
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
11
64
1.73
0.86
1.2
1.2
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
8
44
1.82
0.86
1.6
1.7
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
8
44
1.82
0.86
1.6
1.7
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
13
80
1.63
0.84
3.9
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
13
80
1.63
0.84
3.9
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
13
80
1.63
0.84
3.9
1.5
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
6
31
1.94
0.84
1.7
1.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
24
173
1.40
0.79
1.5
1.5
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
6
33
1.82
0.79
2.0
1.3
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
119
1042
1.16
0.78
1.8
1.7
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
12
74
1.63
0.78
1.6
2.5
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
5
99
0.50
0.78
3.0
3.1
u/ml
30.0
61.4
—
5
99
(3003740) Influenza virus B Ag [Presence] in Specimen
24
174
1.39
0.77
1.1
1.1
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
34
1.77
0.76
2.0
1.2
—
—
—
0
0
(3030905) Polymorphonuclear cells [#/volume] in Blood
25
183
1.37
0.76
4.8
3.4
e9/l
4.1
4.2
0.04
25
183
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
18
124
1.46
0.75
1.3
1.7
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
24
175
1.38
0.75
1.1
1.1
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
27
201
1.35
0.75
1.7
1.4
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
24
2.09
0.74
1.2
1.0
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
15
100
1.51
0.73
1.1
1.1
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
5
25
2.00
0.72
1.0
1.0
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
16
230
0.69
0.72
3.6
3.6
mmol/l
25.1
24.9
0.08
16
203
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
20
142
1.42
0.72
1.5
1.2
u/ml
4.2
5.5
—
9
62
(3014148) Varicella zoster virus Ab [Titer] in Serum
17
117
1.46
0.72
1.2
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
16
109
1.47
0.71
1.0
1.1
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
114
1005
1.15
0.70
3.5
2.8
ug/l
0.6
0.8
2.75
82
619
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
34
266
1.29
0.69
1.4
1.6
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
26
196
1.33
0.68
1.5
2.2
g/l
143.6
128.7
0.81
11
148
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
18
128
1.41
0.66
1.2
1.1
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
25
190
1.32
0.63
5.2
3.7
%
59.3
57.1
0.48
25
190
(3014599) Egg white IgE Ab [Units/volume] in Serum
12
79
1.52
0.62
1.8
1.2
u/ml
94.7
7.3
—
7
31
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
8
49
1.64
0.62
1.8
2.4
—
—
—
0
0
(3029080) Hemoglobin [Entitic mass] in Reticulocytes
6
105
0.57
0.62
2.0
2.1
pg
33.5
32.3
—
6
105
(3021387) Prolactin [Units/volume] in Serum or Plasma
44
362
1.22
0.61
1.5
1.6
mu/l
296.6
306.7
0.07
39
326
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
0
20
0.00
0.60
0.0
1.2
—
—
—
0
0
(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay
0
20
0.00
0.60
0.0
1.2
—
0.9
—
0
14
(44806420)
0
21
0.00
0.60
0.0
2.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
22
0.00
0.59
0.0
1.3
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
6
35
1.72
0.57
1.0
11.5
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
8
54
1.48
0.57
1.5
1.3
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
14
98
1.43
0.56
1.7
1.3
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
14
98
1.43
0.56
1.9
2.4
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
19
141
1.35
0.56
1.6
1.5
—
—
—
0
0
(4146454)
5
89
0.56
0.56
3.0
2.7
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
10
65
1.54
0.55
1.3
1.3
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
15
107
1.41
0.55
1.7
1.9
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
15
107
1.41
0.55
2.3
2.9
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
19
142
1.34
0.54
1.4
1.6
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
27
339
0.79
0.54
3.4
1.8
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
37
304
1.22
0.53
5.9
5.4
kpa
9.5
8.9
0.87
37
286
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
6
39
1.54
0.53
1.2
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
13
91
1.43
0.53
1.4
1.1
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
10
66
1.52
0.52
1.6
1.2
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
12
167
0.72
0.49
2.4
1.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
25
311
0.80
0.48
2.4
1.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
290
2751
1.07
0.46
3.7
3.1
mmol/l
6.6
7.4
2.27
256
2328
(3011288) Drugs identified in Urine by Screen method
31
256
1.22
0.44
1.6
1.9
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
31
371
0.83
0.43
1.4
1.4
—
—
—
0
0
(3024932) HLA-DR beta [Type]
5
31
1.62
0.43
1.2
1.1
—
—
—
0
0
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
5
31
1.62
0.43
1.0
1.5
pmol/l
14.5
13.6
—
5
22
(3024471) HLA-A [Type]
5
31
1.62
0.43
1.0
1.0
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
29
349
0.83
0.42
3.1
1.8
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
5
32
1.56
0.42
2.2
2.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
19
149
1.28
0.42
1.1
1.1
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
77
856
0.89
0.41
3.6
3.2
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
8
58
1.38
0.41
1.0
1.0
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
0
15
0.00
0.41
0.0
2.5
—
—
—
0
0
(3004269) Kappa light chains [Mass/time] in 24 hour Urine
0
15
0.00
0.41
0.0
2.5
—
—
—
0
0
(3021162) Amylase [Enzymatic activity/volume] in Specimen
0
17
0.00
0.40
0.0
2.4
—
4385.0
—
0
17
(3000285) Sodium [Moles/volume] in Blood
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3019779) Phenytoin [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
3.2
—
44.0
—
0
12
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
0
17
0.00
0.40
0.0
1.9
—
6.0
—
0
10
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
5
34
1.47
0.40
2.2
1.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
5
34
1.47
0.40
8.4
1.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
5
34
1.47
0.40
8.4
1.7
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
34
288
1.19
0.39
1.4
1.5
u/l
7.8
9.7
0.68
27
224
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
5
35
1.43
0.39
8.4
1.7
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
5
35
1.43
0.39
1.8
2.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
14
106
1.32
0.39
1.0
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.6
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
9
66
1.37
0.38
1.6
1.2
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
31
365
0.85
0.37
3.0
3.9
%
49.9
48.9
0.09
31
359
(4306422)
18
143
1.26
0.37
1.1
1.2
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
18
143
1.26
0.37
1.2
1.2
u/ml
3.5
5.0
—
6
46
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
48
422
1.14
0.36
12.3
10.7
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
43
375
1.15
0.36
7.3
3.5
%
0.6
0.7
0.40
43
364
(3012516) Albumin [Mass/volume] in Urine
259
2472
1.06
0.36
3.8
3.2
mg/l
1434.4
368.1
1.08
154
1543
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
6
42
1.43
0.35
7.2
1.6
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
6
42
1.43
0.35
7.2
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
6
42
1.43
0.35
7.2
1.6
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
6
42
1.43
0.35
1.0
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
6
42
1.43
0.35
7.2
1.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
120
1116
1.08
0.34
4.6
4.3
%
31.1
32.4
0.81
94
771
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
15
118
1.27
0.33
1.2
1.5
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
10
74
1.35
0.32
1.2
1.2
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
7
52
1.35
0.31
1.0
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
19
157
1.21
0.29
2.2
1.4
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
182
1731
1.06
0.29
5.1
4.5
ug/l
1.7
2.5
1.90
165
1556
(40768441) Liver Pathology biopsy report
10
76
1.32
0.28
1.0
1.5
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
17
140
1.22
0.27
1.1
1.2
%
125.9
115.9
1.00
17
130
(3021901) Oxygen saturation in Capillary blood
13
161
0.81
0.27
2.7
3.1
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
35
394
0.88
0.26
3.3
3.3
mmol/l
26.3
25.1
1.40
35
382
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
5
72
0.69
0.26
1.2
1.8
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
145
1377
1.06
0.25
4.9
4.0
%
22.7
21.3
0.47
69
614
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
24
207
1.16
0.25
2.3
2.3
ug/min
414.3
85.4
—
10
128
(3000764) Benzodiazepines [Presence] in Urine
35
391
0.89
0.24
1.4
1.6
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
5
38
1.32
0.23
1.0
1.0
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
33
369
0.89
0.23
1.8
2.3
u/l
3656.0
4011.3
—
9
160
(3008757) Leukocyte morphology finding [Identifier] in Blood
12
97
1.24
0.23
7.7
4.2
—
—
—
0
0
(3035880) pH of Pleural fluid
5
39
1.28
0.23
1.4
1.2
—
—
—
0
0
(3004451) EKG impression Narrative
5
40
1.25
0.22
1.4
1.3
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
11
0.00
0.21
0.0
11.3
—
—
—
0
0
(40758355) Pancreatic polypeptide [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
2.4
—
54.0
—
0
11
(3017509) Phencyclidine [Presence] in Urine
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3051339) Copper [Moles/volume] in Blood
0
10
0.00
0.21
0.0
1.1
—
17.1
—
0
10
(3016273) Islet cell 512 Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3051101) Glucose [Moles/volume] in Cord blood
0
13
0.00
0.21
0.0
5.5
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
0
14
0.00
0.20
0.0
8.6
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3022621) pH of Urine by Test strip
64
597
1.08
0.20
3.0
2.9
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
92
972
0.94
0.20
1.2
1.3
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
6
50
1.20
0.19
2.0
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
22
193
1.14
0.19
1.8
1.4
u/ml
216.9
247.1
0.21
14
110
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
34
308
1.11
0.19
7.3
7.4
mg/l
1.5
1.4
0.49
34
288
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
7
60
1.17
0.18
2.3
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
7
60
1.17
0.18
2.7
1.9
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
36
392
0.92
0.17
1.4
1.6
—
—
—
0
0
(3006442) Creatine [Moles/volume] in Serum or Plasma
5
66
0.76
0.17
3.0
1.3
—
67.2
—
0
5
(4034850)
28
309
0.90
0.17
12.0
9.6
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
36
391
0.92
0.16
1.4
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
16
139
1.15
0.16
1.4
1.5
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
9
81
1.11
0.15
1.3
1.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
29
266
1.09
0.14
1.2
1.3
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
15
170
0.88
0.13
1.3
1.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
11
128
0.86
0.13
1.0
1.1
—
—
—
0
0
(4281824)
13
113
1.15
0.13
1.3
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
48
452
1.06
0.13
1.4
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
36
386
0.93
0.13
1.4
1.6
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
21
190
1.11
0.12
5.3
3.7
mg/l
32.0
26.3
—
10
117
(3047007) Chlamydophila sp Ab [Presence] in Serum
15
168
0.89
0.11
1.3
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
28
302
0.93
0.11
1.4
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
34
362
0.94
0.10
1.4
1.6
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
16
177
0.90
0.10
1.9
2.6
%
20.7
16.2
—
7
96
(3004119) Hemoglobin [Mass/volume] in Venous blood
52
496
1.05
0.10
6.9
3.9
g/l
126.1
128.4
0.34
52
487
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
25
267
0.93
0.08
1.2
1.3
—
—
—
0
0
(3013512) EKG study
254
2503
1.02
0.08
3.9
3.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
5
62
0.81
0.08
1.2
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
5
62
0.81
0.08
1.0
1.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
24
256
0.94
0.08
1.5
1.4
pmol/l
99.4
223.3
0.97
24
251
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
6
71
0.84
0.07
1.2
1.1
u/ml
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
264
2606
1.02
0.07
4.5
3.9
mg/mmol
8.5
8.4
0.02
159
1606
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
7
85
0.82
0.07
1.3
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
265
2618
1.02
0.07
1.5
1.5
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
11
100
1.10
0.05
1.0
1.1
—
—
—
0
0
(3012501) Base excess in Blood by calculation
17
180
0.94
0.04
5.0
4.0
mmol/l
2.3
2.6
—
10
125
(3014051) Protein [Presence] in Urine by Test strip
21
200
1.05
0.03
1.5
2.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
12
128
0.94
0.02
1.3
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
18
184
0.98
0.00
5.2
3.5
—
—
—
0
0
(3010421) pH of Blood
22
216
1.02
0.00
5.3
3.7
ph
7.4
7.4
0.00
17
177
(3023511) Choriogonadotropin [Units/volume] in Urine
20
202
0.99
0.00
1.3
1.3
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
16
157
1.02
0.00
6.3
3.0
—
—
—
0
0
(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay
0
5
0.00
0.00
0.0
2.6
—
4.1
—
0
5
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018834) Bilirubin.total [Presence] in Urine by Test strip
0
5
0.00
0.00
0.0
2.8
—
—
—
0
0
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3025886) Oxalate [Mass/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.3
—
79.6
—
0
9
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
6
0.00
0.00
0.0
1.2
—
8.1
—
0
6
(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay
0
9
0.00
0.00
0.0
1.1
—
7.2
—
0
9
(3028707) Methadone [Presence] in Urine by Screen method
17
170
1.00
0.00
1.5
1.7
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
12.0
—
—
—
0
0
(3015956) Eosinophils/100 leukocytes in Blood by Manual count
0
6
0.00
0.00
0.0
2.0
—
1.4
—
0
6
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
2.5
—
0
6
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
0
8
0.00
0.00
0.0
1.9
—
4.3
—
0
8
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
6
69
0.87
0.00
1.7
1.6
—
—
—
0
0
(3025549) Creatine [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(4038314)
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
9
0.00
0.00
0.0
2.1
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
8
0.00
0.00
0.0
3.0
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
9
92
0.98
0.00
1.0
1.1
—
—
—
0
0
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint H7_CONJUNCTIVITISCHRON and mortality.

Females

Parameter HR [95% CI] p-value
H7_CONJUNCTIVITISCHRON 1.053 [0.93, 1.19] 0.416
Birth year 0.995 [0.99, 1.0] 0.315

During the follow-up period (1.1.1998 — 31.12.2019), 451 out of 4367 females with H7_CONJUNCTIVITISCHRON died.

Males

Parameter HR [95% CI] p-value
H7_CONJUNCTIVITISCHRON 1.056 [0.9, 1.23] 0.494
Birth year 0.986 [0.98, 1.0] 0.005

During the follow-up period (1.1.1998 — 31.12.2019), 290 out of 2698 males with H7_CONJUNCTIVITISCHRON died.

Mortality risk

Mortality risk for people of age

years, who have H7_CONJUNCTIVITISCHRON.

N-year risk Females Males
1 0.113% 0.184%
5 0.617% 1.142%
10 1.576% 2.972%
15 2.77% 5.727%
20 5.35% 9.739%

Relationships between endpoints

↥

Index endpoint: H7_CONJUNCTIVITISCHRON – Chronic conjunctivitis

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data